Table 2.
Survival analysis in ESCC patients
| 5-years CSS (%) | Log rank (Chi-square) | P-value | |
|---|---|---|---|
| Age (years) | 0.018 | 0.894 | |
| ≤60 | 37.5 | ||
| >60 | 38.0 | ||
| Gender | 0.999 | 0.317 | |
| Female | 46.5 | ||
| Male | 36.4 | ||
| Tumor length (cm) | 17.250 | <0.001 | |
| ≤3.0 | 55.1 | ||
| >3.0 | 31.2 | ||
| Tumor location | 1.132 | 0.568 | |
| Upper | 52.6 | ||
| Middle | 39.1 | ||
| Lower | 34.4 | ||
| Vessel invasion | 14.375 | <0.001 | |
| Negative | 41.6 | ||
| Positive | 19.3 | ||
| Differentiation | 7.105 | 0.029 | |
| Well | 46.0 | ||
| Moderate | 38.3 | ||
| Poor | 30.0 | ||
| T stage | 38.104 | <0.001 | |
| T1 | 67.8 | ||
| T2 | 45.0 | ||
| T3 | 28.0 | ||
| T4 | 21.9 | ||
| N stage | 63.989 | <0.001 | |
| N0 | 53.1 | ||
| N1 | 26.2 | ||
| N2 | 10.0 | ||
| N3 | 8.7 | ||
| Adjuvant therapy | 0.891 | 0.345 | |
| No | 39.4 | ||
| Yes | 34.0 | ||
| GPS | 45.504 | <0.001 | |
| 0 | 49.2 | ||
| 1 | 26.8 | ||
| 2 | 11.9 | ||
| NLR | 29.332 | <0.001 | |
| 0 (≤3.45) | 47.0 | ||
| 1 (>3.45) | 19.3 | ||
| PLR | 34.786 | <0.001 | |
| 0 (≤166.5) | 51.6 | ||
| 1 (>166.5) | 19.7 | ||
| LMR | 28.609 | <0.001 | |
| 0 (>2.30) | 51.8 | ||
| 1 (≤2.30) | 22.8 |